Semaglutide News and Research

Latest Semaglutide News and Research

UTHSC researchers receive $1.98 million grant for novel approach to studying diabetes

A team of researchers in the University of Tennessee Health Science Center's College of Medicine has been awarded a $1.98 million grant from the National Institute of Diabetes and Digestive and Kidney Disease, a division of the National Institutes of Health, for a novel approach to studying diabetes.

3 Feb 2020

Scientists evaluate HIV/AIDS, diabetes and organ transplant drugs as possible therapies for Alzheimer's

More than ever before, Alzheimer's researchers understand that a variety of approaches will be needed - most likely used in combination - for effective treatment of the disease.

18 Dec 2019

Penn researchers receive nearly $5 million to reduce opioid cravings

Opioid overdoses take the lives of tens of thousands of Americans annually. Two researchers from Penn State College of Medicine have received nearly $5 million from the National Institutes of Health to study whether an already-approved drug can be used to reduce cravings and prevent relapse in those struggling with opioid addiction.

9 Dec 2019

GLP-1 receptors could serve as targets for novel medications to treat opioid use disorder

Opioid use disorder and overdose deaths are a major public health crisis in the United States. While medication-assisted treatments for opioid use disorder exist, these treatments remain inadequate for many patients, resulting in a high rate of relapse following detoxification.

31 Oct 2019

Study explores distribution of new diabetes cases and specialist density in the U.S.

In the last five years, the landscape of type 2 diabetes treatment has changed dramatically. Two new classes of drugs -- SGLT2 inhibitors and GLP-1 receptor agonists -- have been shown to prevent some of the most serious diabetes complications, including heart and kidney conditions, in patients.

25 Oct 2019

Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories

Tecan’s range of advanced liquid handling solutions will soon be enhanced with the introduction of the new Fluent® Gx Automation Workstation, designed specifically to meet the stringent needs of clinical and regulated laboratories.

From Tecan 29 Aug 2019

New injection helps reduce body weight, glucose levels in patients with obesity

An injection has helped reduce body weight and glucose levels in patients with diabetes and obesity in four weeks.

6 Aug 2019

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

A new study has shown that SGLT-2 inhibitors used in the treatment of type 2 diabetes do not increase the risk of UTIs over other anti-diabetic medications.

31 Jul 2019

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.

18 Jun 2019

Diabetes drug reduces cardiovascular events and kidney problems, study finds

A clinical trial that followed more than 9,900 people in 24 countries has found that the drug dulaglutide reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes.

10 Jun 2019

No lasting improvement in insulin secretion with diabetic medication

Adults with type 2 diabetes mellitus respond to medical treatment by producing more insulin, but there is no long-term effect on insulin secretion after treatment stops, concluded a pair of clinical trials.

9 Jun 2019

Diabetes drug could help with smoking cessation

Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston

30 Apr 2019

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

Study provides framework for developing Ebola virus therapeutic under FDA Animal Rule

The U.S. Army Medical Research Institute of Infectious Diseases today announced that, for the first time, the U.S. Food and Drug Administration has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus infections.

29 Mar 2019

New Metrohm Eco Titrator makes titration simple, safe, and reliable

When something goes wrong in quality control, the reputation of the brand concerned is at stake. Better to exclude risks in the first place.

From Metrohm USA Inc. 15 Mar 2019

Bariatric surgery changes the way our body senses food

How bariatric surgery helps people with obesity and diabetes is related to changes in the way the gut senses food and nutrients after the operation, researchers report February 5 in the journal Cell Reports.

8 Feb 2019

The T2B Infrastructure Center for Respiratory Disease set to enter into the final phase

The Korea Institute of Toxicology (KIT·Chief Dr. Song, Chang-woo) National Center for Efficacy Evaluation of Respiratory Disease Product (NCER·Chief Dr. Lee, Kyu-hong) obtained on January 10 the final decision from the Ministry of Health and Welfare that the T2B Infrastructure Center for Respiratory Disease would enter into the final phase (second phase) with funding of 3 billion KRW over two years.

4 Feb 2019

Gut immune cells could be responsible for metabolism changes finds study

A new study has shown that the immune cells within the gut could be related to the rate of metabolism. The results of the new study titled, “Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease,” are published in the latest issue of the journal Nature.

31 Jan 2019

New bacterial species may help fight obesity and metabolic disorders

The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression).

17 Dec 2018

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.

6 Dec 2018

Semaglutide News and Research

Latest Semaglutide News and Research

UTHSC researchers receive $1.98 million grant for novel approach to studying diabetes

Scientists evaluate HIV/AIDS, diabetes and organ transplant drugs as possible therapies for Alzheimer's

Penn researchers receive nearly $5 million to reduce opioid cravings

GLP-1 receptors could serve as targets for novel medications to treat opioid use disorder

Study explores distribution of new diabetes cases and specialist density in the U.S.

Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories

New injection helps reduce body weight, glucose levels in patients with obesity

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

FDA approves first non-insulin drug for treatment of pediatric patients with type 2 diabetes

Diabetes drug reduces cardiovascular events and kidney problems, study finds

No lasting improvement in insulin secretion with diabetic medication

Diabetes drug could help with smoking cessation

Study results of a potential drug to treat Type 2 diabetes in children announced

Study provides framework for developing Ebola virus therapeutic under FDA Animal Rule

New Metrohm Eco Titrator makes titration simple, safe, and reliable

Bariatric surgery changes the way our body senses food

The T2B Infrastructure Center for Respiratory Disease set to enter into the final phase

Gut immune cells could be responsible for metabolism changes finds study

New bacterial species may help fight obesity and metabolic disorders

Liraglutide drug associated with lower risk of cardiovascular events

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Semaglutide News and Research

Latest Semaglutide News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in